Ciphergen CEO Joins Genomica s Board of Directors | GenomeWeb

NEW YORK, March 14 – Bioinformatics company Genomica said Wednesday it had appointed William Rich, CEO of Ciphergen Biosystems, to its board of directors, signaling the company’s growing interest in the field of proteomics.

"His experience in the industry in general and, in particular, the emerging field of protein-based biology research known as proteomics, will help us as we expand our product line and functionality," Teresa Ayers, CEO of Genomica, said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.